escitalopram / Generic mfg. |
NCT00648570: Fasting Study of Escitalopram Oxalate Tablets 20 mg and Lexapro® Tablets 20 mg |
|
|
| Completed | 1 | 37 | US | Escitalopram Oxalate Tablets 20 mg, Lexapro® Tablets (20 mg | Mylan Pharmaceuticals Inc | Healthy | 10/04 | 10/04 | | |
NCT00648661: Food Study of Escitalopram Oxalate Tablets 20 mg to Lexapro® Tablets 20 mg |
|
|
| Completed | 1 | 35 | US | Escitalopram Oxalate Tablets 20 mg, Lexapro® Tablets 20 mg | Mylan Pharmaceuticals Inc | Healthy | 10/04 | 10/04 | | |
NCT00361790: Aripiprazole and Lexapro Drug Interaction Study |
|
|
| Completed | 1 | 25 | US | Escitalopram on days -7 to day 14; Aripiprazole dosed starting Day 1 to day 14: 3 days at 10 mg, 4 days at 15 mg and 7 days at 20 mg, Abilify | Otsuka Pharmaceutical Development & Commercialization, Inc. | Healthy | 11/06 | 11/06 | | |
NCT00414323: Evaluation of the Effects of Duloxetine on Norepinephrine |
|
|
| Completed | 1 | 35 | US | Duloxetine, Escitalopram, Placebo | Eli Lilly and Company | Major Depressive Disorder | | 05/07 | | |
NCT01996475: Bioequivalence Study of Torrent Pharmaceutical Ltd.'s of Escitalopram Oxalate Tablets Under Fed Condition |
|
|
| Completed | 1 | | RoW | Escitalopram Oxalate Tablets | Torrent Pharmaceuticals Limited | Healthy | 05/08 | | | |
NCT01996462: Bioequivalence Study of Torrent Pharmaceutical Ltd.'s of Escitalopram Oxalate Tablets Under Fasting Condition |
|
|
| Completed | 1 | | RoW | Escitalopram Oxalate Tablets | Torrent Pharmaceuticals Limited | Healthy | 05/08 | | | |
NCT00656552: Safety and Efficacy of Escitalopram in the Treatment of Premature Ejaculation |
|
|
| Unknown status | 1 | 100 | RoW | Escitalopram | Cairo University | Premature Ejaculation | 12/08 | | | |
NCT00933894: VX-950-TiDP24-C133 - A Phase I Study Investigating the Interaction Between Telaprevir and Escitalopram |
|
|
| Completed | 1 | 16 | RoW | Telaprevir; Escitalopram | Tibotec BVBA | Hepatitis C | 11/09 | 11/09 | | |
| Terminated | 1 | 1 | Canada | Escitalopram, Cipralex, placebo | Queen's University | Bipolar Depression | 01/10 | 01/10 | | |
NCT01395433: Bioequivalence Study Comparing Two Formulations of Escitalopram |
|
|
| Completed | 1 | 32 | Europe | Escitalopram | H. Lundbeck A/S | Healthy | 03/10 | | | |
NCT01745601: Bioequivalence Study of Escitalopram Tablets 10 mg |
|
|
| Completed | 1 | 26 | NA | escitalopram 10 mg, Lexapro® LUNDBECK MEXICO SA de CV, escitalopram GLAXOSMITHKLINE MEXICO SA de CV | GlaxoSmithKline | Anxiety Disorders | 05/10 | 05/10 | | |
NCT01090700: TMC435-TiDP16-C112 - Interaction Trial With Antidepressants |
|
|
| Completed | 1 | 20 | Europe | TMC435, Escitalopram, TMC435 + Escitalopram | Tibotec Pharmaceuticals, Ireland | Hepatitis C Virus | 09/10 | 09/10 | | |
NCT01638689: A PET Study to Determine Alterations in Serotonin Levels in Human Brain After a Single Dose of Escitalopram |
|
|
| Completed | 1 | 10 | Europe | Escitalopram | Karolinska Institutet | Healthy | 02/11 | 07/12 | | |
NCT01045083: A Study of the Ability of Functional Magnetic Resonance Imaging (fMRI) to Detect and Characterize the Effects of Two Marketed Centrally Active Drugs, Placebo, and RO4917523 in Healthy Volunteers |
|
|
| Completed | 1 | 25 | US | RO4917523, escitalopram, Lexapro, methylphenidate, Ritalin, placebo | Hoffmann-La Roche | Healthy Volunteer | 06/11 | 06/11 | | |
| Completed | 1 | 98 | US | SSRI, Lexapro, escitalopram, Prozac, fluoxetine, Sertraline, Zoloft, CBT, CT, Cognitive Therapy | University of Pittsburgh, The Pittsburgh Foundation, National Institute of Mental Health (NIMH) | Major Depressive Disorder | 07/11 | 07/11 | | |
NCT01601730: Modafinil - Escitalopram Study for Cocaine Dependence |
|
|
| Completed | 1 | 68 | US | Modafinil and Escitalopram, Provigil, Lexapro, Placebo, Sugar pill, Modafinil, Escitalopram | Baylor College of Medicine, National Institute on Drug Abuse (NIDA) | Cocaine Dependence, Cocaine Abuse, Cocaine Addiction, Substance Abuse | 07/11 | 07/11 | | |
NCT01418274: A Study to Evaluate the Effect of Danoprevir/Ritonavir on the Pharmacokinetics of Escitalopram and S-Demethylcitalopram in Healthy Volunteers |
|
|
| Completed | 1 | 20 | US | danoprevir, escitalopram, ritonavir | Hoffmann-La Roche | Healthy Volunteer | 09/11 | 09/11 | | |
NCT01751854: Enhanced Motor Recovery Using Serotonergic Agents in Stroke |
|
|
| Completed | 1 | 30 | US | SSRI, escitalopram, Placebo | Shirley Ryan AbilityLab | Patients With Chronic Stroke | 01/12 | 01/12 | | |
| Unknown status | 1 | 30 | Canada | Cipralex®, Chemical/Pharmaceutical alternative name: Escitalopram | University of Ottawa, H. Lundbeck A/S | Anxiety Disorder | 01/12 | 01/12 | | |
| Completed | 1 | 927 | US | citalopram and escitalopram | Mayo Clinic, National Institute of General Medical Sciences (NIGMS), National Center for Research Resources (NCRR) | Depression | 05/13 | 05/13 | | |
ChiCTR-TRC-13003179: The different effects of agomelatine and escitalopram on the circadian rhythmic system in the first episode depressive patients |
|
|
| Completed | 1 | 90 | | agomelatine 25-50mg per day before sleep ;escitalopram 10-20mg per day after breakfast ;No intervention | National Institute on Drug Dependence, Peking University; Level of the institution:, Natural Science Foundation of China | Depression | | | | |
NCT02122939: A Clinical Trial to Investigate the Pharmacokinetics and the Effect on ECG of Escitalopram in Elderly Volunteers |
|
|
| Completed | 1 | 12 | RoW | Escitalopram | Seoul National University Hospital | Healthy | 03/14 | 03/14 | | |
NCT01871701: Clinical Trial to Investigate the Effect on Corrected QT Interval Prolongation by Psychotropic Drugs |
|
|
| Completed | 1 | 40 | RoW | Escitalopram, Escitalopram 20 mg (Lexapro, Tablet), Quetiapine, Quetiapine 100 mg (Seroquel, Tablet), Moxifloxacin, Moxifloxacin 400 mg (Avelox, Tablet), Placebo, Water intake | Seoul National University Hospital, Seoul National University Bundang Hospital | Healthy | 05/14 | 05/14 | | |
NCT02175602: Study of Drug Combination on Pharmacokinetics in Healthy Volunteers |
|
|
| Completed | 1 | 41 | US | Escitalopram, Lexapro, Sertraline, Zoloft, DCV 3DAA FDC, BMS-791325 | Bristol-Myers Squibb | Hepatitis C Infection | 08/14 | | | |
NCT02072278: Electroencephalography Study Investigating the Effects of Vortioxetine in Healthy Male Subjects |
|
|
| Completed | 1 | 32 | Europe | Vortioxetine 10 mg, Vortioxetine 20 mg, Escitalopram 15 mg, Placebo | H. Lundbeck A/S | Healthy Men | 11/14 | | | |
NCT01788969: Serotonergic Modulation of Motor Function in Subacute and Chronic SCI |
|
|
| Unknown status | 1 | 42 | US | Lexapro, escitalopram, Placebo, microcrystalline dextrose | Shirley Ryan AbilityLab | Spinal Cord Injury | 12/16 | 12/19 | | |
| Completed | 1 | 100 | Europe | Escitalopram, Duloxetine | Rigshospitalet, Denmark, Center for Integrated Molecular Brain Imaging, Copenhagen, Denmak, Psychiatric Centre Copenhagen, Central Visitation, Region Hovedstaden | Major Depressive Disorder | 07/19 | 07/19 | | |
NCT03274817: A Proof of Concept Study of the Prevention of Mild Cognitive Impairment and Eventual Alzheimer's Disease Using F18 Flutemetamol |
|
|
| Terminated | 1 | 5 | US | Escitalopram Pill, Lexapro, Venlafaxine Pill, Effexor XR, Placebo Oral Tablet | NYU Langone Health | Alzheimer Disease | 09/19 | 09/19 | | |
NCT01753882: Monoaminergic Modulation of Motor Function in Subacute Incomplete Spinal Cord Injury (SCI) |
|
|
| Unknown status | 1 | 88 | US | Lexapro, escitalopram, Placebo, microcrystalline dextrose | Shirley Ryan AbilityLab | Spinal Cord Injury | 07/20 | 07/20 | | |
NCT03912974: Effects of SERT Inhibition on the Subjective Response to Psilocybin in Healthy Subjects |
|
|
| Completed | 1 | 27 | Europe | Escitalopram, Placebo oral capsule | University Hospital, Basel, Switzerland | Healthy | 11/20 | 11/20 | | |
NCT03887624: Investigate the Clinical Responses of Ethosuximide in Patients With Treatment-Resistant Depression. |
|
|
| Terminated | 1 | 16 | RoW | Ethosuximide, Zarontin, Placebo, Placebo(for Ethosuximide), Escitalopram, Lexapro | Zhejiang University | Depressive Disorder, Treatment-Resistant | 04/21 | 04/21 | | |
| Not yet recruiting | 1 | 200 | | Genotyping | Institute of Clinical Pharmacology, Central South University; Changsha Central Hospital, raise independently | healthy subjects | | | | |
NCT03623711: A Prediction Study of Multiple Indexes of the Effect of Different Mechanisms of Antidepressants Treatment on Depression |
|
|
| Recruiting | 1 | 200 | RoW | Escitalopram, Lexapro, Duloxetine, cymbalta, Bupropion, bupropion hydrochloride tablets, Healthy control, placebo tablets | Yuqi Cheng | Major Depressive Disorder, Depression, Unipolar | 12/22 | 12/22 | | |
ChiCTR2300071340: Study on Individual and Group Intervention Models of Yishu Psychodrama Technology in the Treatment and Rehabilitation of Outpatient Depression |
|
|
| Completed | 1 | 50 | | Yi Shu psychodrama treatment ;first-line antidepressant (escitalopram oxalate) treatment | The First Affiliated Hospital of Chongqing Medical University; The First Affiliated Hospital of Chongqing Medical University, Chongqing Technology Innovation and Application Demonstration Project | Depression | | | | |
NCT05470465: Effect of Selective Serotonin Reuptake Inhibitors (SSRIs) and an Opioid on Ventilation |
|
|
| Completed | 1 | 27 | US | Placebo and Oxycodone, Paroxetine and Oxycodone, Escitalopram and Oxycodone | Food and Drug Administration (FDA), Spaulding Clinical Research LLC, Leiden University | Hypercapnia, Ventilatory Depression | 09/23 | 09/23 | | |
NCT06476509: A Study to Assess Serotonin Transporter Occupancy of Healthy Adults Using 11C-DASB PET |
|
|
| Not yet recruiting | 1 | 8 | NA | LV232 40mg, LV232, Escitalopram 20 mg, Escitalopram | Vigonvita Life Sciences | Major Depressive Disorder | 09/24 | 10/24 | | |
ChiCTR2300070230: Evaluation of psychosocial factors in patients with functional gastroenterology and prediction of efficacy of escitalopram |
|
|
| Not yet recruiting | 1 | 218 | | no ;no | Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology; Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, National Natural Science Foundation of China (No. 82090034) | functional gastroenterology | | | | |